Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial - PubMed (original) (raw)
Randomized Controlled Trial
. 2015 Aug;213(2):194.e1-8.
doi: 10.1016/j.ajog.2015.04.003. Epub 2015 Apr 13.
Affiliations
- PMID: 25882919
- PMCID: PMC4519382
- DOI: 10.1016/j.ajog.2015.04.003
Randomized Controlled Trial
Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial
Betsy Foxman et al. Am J Obstet Gynecol. 2015 Aug.
Abstract
Objective: The risk of urinary tract infection (UTI) among women undergoing elective gynecological surgery during which a catheter is placed is high: 10-64% following catheter removal. We conducted the first randomized, double-blind, placebo-controlled trial of the therapeutic efficacy of cranberry juice capsules in preventing UTI after surgery.
Study design: We recruited patients from a single hospital between August 2011 and January 2013. Eligible participants were undergoing elective gynecological surgery that did not involve a fistula repair or vaginal mesh removal. One hundred sixty patients were randomized and received 2 cranberry juice capsules 2 times a day, equivalent to 2 8 ounce servings of cranberry juice, for 6 weeks after surgery or matching placebo. The primary endpoint was the proportion of participants who experienced clinically diagnosed and treated UTI with or without positive urine culture. Kaplan-Meier plots and log rank tests compared the 2 treatment groups.
Results: The occurrence of UTI was significantly lower in the cranberry treatment group compared with the placebo group (15 of 80 [19%] vs 30 of 80 [38%]; odds ratio, 0.38; 95% confidence interval, 0.19-0.79; P = .008). After adjustment for known confounders, including the frequency of intermittent self-catheterization in the postoperative period, the protective effects of cranberry remained (odds ratio, 0.42; 95% confidence interval, 0.18-0.94). There were no treatment differences in the incidence of adverse events, including gastrointestinal upset (56% vs 61% for cranberry vs placebo).
Conclusion: Among women undergoing elective benign gynecological surgery involving urinary catheterization, the use of cranberry extract capsules during the postoperative period reduced the rate of UTI by half.
Keywords: catheter-associated urinary tract infection; clinical trial; cranberry extract.
Copyright © 2015 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors report no conflicts of interest.
Figures
Figure 1. CONSORT flow diagram
Enrollment and exclusions, allocation to treatment, follow-up and reasons for loss.
Figure 2. Time to urinary tract infection by treatment group
Kaplan-Meier estimates and 95% Hall-Wellner confidence bands are provided by treatment group. The number at risk for UTI is shown on the horizontal axis.
Comment in
- Urine trouble without cranberries?
Whiteside JL. Whiteside JL. Am J Obstet Gynecol. 2015 Aug;213(2):123-4. doi: 10.1016/j.ajog.2015.04.030. Am J Obstet Gynecol. 2015. PMID: 26216179 No abstract available.
References
- Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010 Mar 1;50(5):625–663. -PubMed
- Falagas ME, Athanasiou S, Iavazzo C, Tokas T, Antsaklis A. Urinary tract infections after pelvic floor gynecological surgery: prevalence and effect of antimicrobial prophylaxis. A systematic review. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Aug;19(8):1165–1172. -PubMed
- Foxman B. Urinary Tract Infection Syndromes: Occurrence, Recurrence, Bacteriology, Risk Factors, and Disease Burden. Infect Dis Clin North Am. 2014 Mar;28(1):1–13. -PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UL1 TR000433/TR/NCATS NIH HHS/United States
- K12 HD001438/HD/NICHD NIH HHS/United States
- R21-DK-085290/DK/NIDDK NIH HHS/United States
- K12-HD-001438/HD/NICHD NIH HHS/United States
- R21 DK085290/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical